Larimar Therapeutics, Inc.

LRMR

—

Advanced chart & tools →

Larimar Therapeutics, Inc.LRMR

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-1.32

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

Net income

$-165.67M

Net margin

—

Gross margin

—

Dividends & financials

Larimar Therapeutics, Inc. (LRMR) reported revenue of $0 and net income of $-165.67M, or $-1.32 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.